MARKET

NRXS

NRXS

Neuraxis Inc
AMEX
2.250
-0.110
-4.66%
Closed 15:49 05/16 EDT
OPEN
2.240
PREV CLOSE
2.360
HIGH
2.400
LOW
2.070
VOLUME
16.41K
TURNOVER
--
52 WEEK HIGH
3.780
52 WEEK LOW
1.330
MARKET CAP
16.24M
P/E (TTM)
-1.8417
1D
5D
1M
3M
1Y
5Y
1D
NeurAxis Stock Gains Following Strong Q1 Earnings and FDA Milestones
NASDAQ · 3d ago
NeurAxis, Inc. Reports Increased Sales Amidst Losses
TipRanks · 5d ago
NeurAxis GAAP EPS of -$0.33, revenue of $0.89M
Seeking Alpha · 6d ago
NeurAxis GAAP EPS of -$0.33, revenue of $0.90M misses by $724.1M
Seeking Alpha · 6d ago
*Neuraxis 1Q Sales $895,655 >NRXS
Dow Jones · 6d ago
*Neuraxis 1Q Loss/Shr 33c >NRXS
Dow Jones · 6d ago
Press Release: NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues
Dow Jones · 6d ago
Press Release: NeurAxis Reports Strong First -2-
Dow Jones · 6d ago
More
About NRXS
Neuraxis, Inc. is a medical technology company. The Company is focused on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults. It focuses on advancing science and leveraging evidence-based medicine to drive the adoption of its IB-Stim therapy, which is its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, by the medical, scientific, and patient communities. IB-Stim is a food and drug administration (FDA) cleared for functional abdominal pain associated with irritable bowel syndrome (IBS) in adolescents 11-18 years old. The Company’s second product, the Rectal Expulsion Device (RED), is indicated to evaluate the neuromuscular function of a patient’s ability to expel its contents from the rectum and as a qualitative test for rectal hypersensitivity. RED (K242304, 2024) helps identify patients with rectal hypersensitivity who experience a desire or urge defecating at lower volumes of distension.

Webull offers Neuraxis Inc stock information, including AMEX: NRXS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRXS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRXS stock methods without spending real money on the virtual paper trading platform.